Buy Spotify (SPOT) on Selloff - Monness, Crespi, Hardt
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/25/2024
- Wall Street stocks fall as weak GDP growth spreads rate-cut gloom
- Q1 US GDP shows surprise slowing and uncomfortable inflation
- Alphabet (GOOGL) soars 16% on Q1 results beat, first-ever dividend
- Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
- Oil settles higher as weak U.S. economic growth offset by supply concerns
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hasbro (HAS) brand strength sees earnings top expectations
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- After-hours movers: Alphabet, Microsoft, Snap, Intel, and more
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
Spotify (SPOT) Plunges 9% on Weak Total Users Figures But Growth Thesis Remains Intact Says Analyst
April 28, 2021 12:04 PM EDTShares of Spotify (NYSE: SPOT) are down 9% in todays trading session after the company missed on analysts estimates for monthly active users (MAUs).
SPOT said it made a loss of $0.30 a share on revenue of $2.59 billion for the first quarter to end-March. This compared with the expected loss of $0.49 per share, while the revenue came in line with expectations.
The company... More
Pre-Open Stock Movers 04/28: (ADMA) (G) (GOOGL) Higher; (PLX) (PINS) (RRD) Lower (more...)
April 28, 2021 9:30 AM EDTPre-Open Stock Movers
Protalix BioTherapeutics, Inc. (NYSE: PLX) 42% LOWER; announced that they received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the Biologics License Application (BLA) seeking accelerated approval of pegunigalsidase alfa (PRX102) for the proposed treatment of adult patients with Fabry disease.
ADMA Biologics, Inc. (Nasdaq: ADMA) 20% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted approval for the Companys expanded manufacturing process, enabling fractionation and... More
Spotify (SPOT) Reports Q1 Loss of EUR0.25 on Revenues of EUR2.15B; Offers 2Q & FY21 Revenue Outlook
April 28, 2021 6:08 AM EDTSpotify (NYSE: SPOT) reported Q1 EPS of (EUR0.25), versus (EUR0.20) reported last year. Revenue for the quarter came in at EUR2.15 billion, versus EUR1.85 billion reported last year.
GUIDANCE:
Spotify sees Q2 2021 revenue of EUR2.16-2.36 billion.
Spotify sees FY2021 revenue of EUR9.11-9.51 billion.
Q2 & 2021 OUTLOOK
The following forward-looking... More
